This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +22.98% per year. These returns cover a period from January 1, 1988 through April 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
ICON's Q1 Earnings Surpass Estimates, Revenues Lag, Stock Down
by Zacks Equity Research
ICLR posts mixed results in the first quarter of 2025 due to ongoing clinical development and market volatility.
BSXNegative Net Change ANGONegative Net Change ICLRNegative Net Change ITGRNegative Net Change
earnings medical medical-devices
CVS Q1 Earnings & Revenues Beat, '25 EPS View Raised, Stock Up
by Zacks Equity Research
CVS Health delivers earnings and revenue beat in the first quarter of 2025.
BSXNegative Net Change ANGONegative Net Change CVSNegative Net Change ITGRNegative Net Change
earnings medical medical-devices
CNMD Stock Up On Q1 Earnings & Sales Beat, Raised 2025 Outlook
by Zacks Equity Research
CNMD reports solid first-quarter results, driven by improving sales across both segments.
CNMDNegative Net Change MASIPositive Net Change FMSPositive Net Change AHCOPositive Net Change
earnings medical medical-devices
4 MedTech Stocks Poised to Outshine Q1 Earnings Estimates
by Indrajit Bandyopadhyay
MedTech companies' quarterly results are likely to reflect base business recovery on a year-over-year basis. Let's see how HIMS, GMED, QDRL and HAE are poised ahead of their earnings release.
HAEPositive Net Change QDELNegative Net Change GMEDNegative Net Change HIMSPositive Net Change
medical medical-devices
Hims & Hers vs. Teladoc: Which Telehealth Stock Is the Better Buy Now?
by Debanjana Dey
Both HIMS and TDOC are technology-intensive healthcare companies that leverage their strengths in the digital health space to enhance their platforms. Which one is a better investment? Let's see.
TDOCPositive Net Change HIMSPositive Net Change
medical medical-devices
GE HealthCare Q1 Earnings & Sales Beat Estimates, Net Margin Rises
by Zacks Equity Research
GEHC's first-quarter results reflect strength in the Imaging and Pharmaceutical Diagnostics segments. The bottom line improves on better pricing.
MASIPositive Net Change FMSPositive Net Change AHCOPositive Net Change GEHCNegative Net Change
earnings medical medical-devices
MedTech Stocks' Earnings to Watch on May 1: BDX, CAH, BAX, DXCM & SYK
by Harshit Gupta
The medical device industry is growing fast in 2025, but faces supply and trade issues. Major companies to report earnings on May 1, stay tuned!
BDXNegative Net Change BAXNegative Net Change SYKNegative Net Change CAHPositive Net Change DXCMNegative Net Change
medical medical-devices
Watch These 3 MedTech Stocks This Earnings Season: Beat or Miss?
by Moumi Mondal
MedTech bigwigs, such as CVS, HOLX and IDXX, are set to post their quarterly results tomorrow. Can they deliver on expectations?
HOLXPositive Net Change CVSNegative Net Change IDXXPositive Net Change
earnings medical medical-devices
Strong Segmental Performance to Drive Stryker's Q1 Earnings?
by Zacks Equity Research
SYK's first-quarter 2025 results are expected to reflect strong segmental performance. However, rising costs are likely to have continued to hurt margins.
SYKNegative Net Change ANegative Net Change EDAPPositive Net Change GMEDNegative Net Change
medical medical-devices
ECL Stock Up in Pre-Market Following Q1 Earnings Meet Estimates
by Zacks Equity Research
Ecolab's robust performance across the majority of its segments drives its first-quarter organic sales despite business challenges.
ECLNegative Net Change MASIPositive Net Change FMSPositive Net Change GKOSNegative Net Change
earnings medical medical-devices
Can Sustained Product Demand Drive CAH Stock Before Q3 Earnings?
by Zacks Equity Research
The continued solid uptake of Cardinal Health's products is expected to have driven fiscal third-quarter revenues despite an uncertain macroeconomic environment.
BDXNegative Net Change ALGNPositive Net Change CAHPositive Net Change HSICNegative Net Change
earnings medical medical-devices
Eldorado Gold Corporation (EGO) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
EGOPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
ISRG vs. SYK: Which Robotic-Device Innovator Is a Better Buy?
by Indrajit Bandyopadhyay
Both are leaders in robotic-assisted surgery ??? Intuitive Surgical in soft tissue procedures and Stryker in orthopedic surgeries. Which company is a better bet now?
SYKNegative Net Change ISRGNegative Net Change
medical medical-devices
DXCM Q1 Earnings to Reflect U.S. Coverage Expansion & Stelo Impact?
by Zacks Equity Research
DexCom Q1 results are likely to reflect strong growth on the back of coverage by two large PBMs and Stelo traction, driving momentum and market expansion in 2025.
ANegative Net Change DXCMNegative Net Change EDAPPositive Net Change GMEDNegative Net Change
medical medical-devices
Labcorp Q1 Earnings Surpass Estimates, Revenues Miss, Stock Gains
by Zacks Equity Research
LH delivers better-than-expected earnings in the first quarter of 2025.
BSXNegative Net Change LHNegative Net Change ANGONegative Net Change ITGRNegative Net Change
earnings medical medical-devices
Tempus AI Stock Surges 43% in Q1: Buy Now or Wait for Earnings?
by Urmimala Biswas
TEM's Genomics unit is expected to report strong growth for the first quarter, banking on continued unit growth pick-up.
TXGPositive Net Change SOPHNegative Net Change TEMNegative Net Change
artificial-intelligence earnings-estimates-revisions earnings-outlook earnings-preview earnings-report earnings-streak earnings-surprise healthcare medical-devices
EMEA Growth & Product Launches to Support Boston Scientific Stock
by Zacks Equity Research
Boston Scientific successfully continues with its expansion of operations across different geographies outside the United States.
BSXNegative Net Change MASIPositive Net Change PBHPositive Net Change HIMSPositive Net Change
medical medical-devices
Will BAX's Q1 Earnings Improve Following Transformation Completion?
by Zacks Equity Research
Baxter's first-quarter results are likely to reflect the favorable impact of kidney care sales. Growth in infusion therapies, pharmaceuticals and patient support systems to continue.
BAXNegative Net Change ANegative Net Change EDAPPositive Net Change GMEDNegative Net Change
medical medical-devices
RVTY Rises as Q1 Earnings & Sales Beat Estimates, '25 Sales View Up
by Zacks Equity Research
Revvity's first-quarter results showcase strong growth in Diagnostics business, along with recovery in Life Sciences segmental sales.
MASIPositive Net Change FMSPositive Net Change GKOSNegative Net Change RVTYNegative Net Change
earnings medical medical-devices
Can Sustained Product Demand Drive BDX Stock Before Q2 Earnings?
by Zacks Equity Research
The continued solid uptake of BD's products is expected to have driven fiscal second-quarter revenues despite transitory market dynamics.
BDXNegative Net Change CAHPositive Net Change HSICNegative Net Change MMSINegative Net Change
earnings medical medical-devices
Avantor Stock Declines Despite Q1 Earnings In-Line, Revenues Down Y/Y
by Zacks Equity Research
AVTR's Bioscience Production segment witnesses robust growth amid macroeconomic pressures.
MASIPositive Net Change FMSPositive Net Change GKOSNegative Net Change AVTRNegative Net Change
earnings medical medical-devices
Should You Buy, Sell, or Hold GE Healthcare Before Q1 Earnings?
by Zacks Equity Research
GEHC Q1 results are likely to reflect strong growth in Imaging, Ultrasound, and AI, fueled by robust procedure volumes and global partnerships despite China headwinds.
CORNegative Net Change ANIPNegative Net Change HIMSPositive Net Change GEHCNegative Net Change
medical medical-devices
StoneCo Ltd. (STNE)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
STNENegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Here's How Charles River is Placed Just Ahead of Q1 Earnings
by Zacks Equity Research
CRL's first-quarter 2025 performance is expected to have been hurt by a challenging biopharmaceutical environment.
CRLNegative Net Change CORNegative Net Change ANIPNegative Net Change HIMSPositive Net Change
earnings medical medical-devices
GYN Surgical Division Likely to Drive Hologic's Q2 Earnings
by Zacks Equity Research
HOLX's second-quarter fiscal 2025 performance is likely to have benefited from expanding breast health offerings.
HOLXPositive Net Change CORNegative Net Change ANIPNegative Net Change HIMSPositive Net Change
earnings medical medical-devices